At a glance
- Samplix announced the first close in October 2026.
- WLanholding's first close included €22 million of bond conversions and €3 million in fresh capital.
- Family offices evaluating the round are effectively looking at only €3 million of fresh capital.
WLanholding, the private investment company of former Evotec chief executive Werner Lanthaler, led a €25 million first close for Samplix, Family Office Hub reported. Samplix announced the first close in October 2026. Lanthaler is lead investor and will join Samplix's board.
WLanholding's first close included €22 million of bond conversions and €3 million in fresh capital. Samplix develops droplet microfluidics for biopharma research and will use the proceeds to expand its Xdrop platform and deepen partnerships with biopharma and academic groups.
Family offices evaluating the round are effectively looking at only €3 million of fresh capital.
The Xdrop platform puts living cells into double-emulsion droplets that standard flow cytometers and cell sorters can read.
Most of the €25m first close was converted debt
First close of €25m split between converted shareholder bonds and new capital, Oct. 2026
- Converted bonds88%22 €M
- New capital12%3 €M
Show as table
| Part | Value | Share |
|---|---|---|
| Converted bonds | 22 | 88% |
| New capital | 3 | 12% |
Reported by the Direct & Co-Investments desk from Family Office Hub. Published . Corrections